Compare AIT & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIT | GH |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 10.9B |
| IPO Year | 1994 | 2018 |
| Metric | AIT | GH |
|---|---|---|
| Price | $305.28 | $86.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 19 |
| Target Price | ★ $317.50 | $119.79 |
| AVG Volume (30 Days) | 248.0K | ★ 2.1M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | 2.95 | ★ 6.74 |
| EPS | ★ 7.79 | N/A |
| Revenue | $21,485,000.00 | ★ $982,021,000.00 |
| Revenue This Year | $7.79 | $33.30 |
| Revenue Next Year | $5.45 | $28.27 |
| P/E Ratio | $39.26 | ★ N/A |
| Revenue Growth | N/A | ★ 32.88 |
| 52 Week Low | $213.78 | $36.36 |
| 52 Week High | $309.67 | $120.74 |
| Indicator | AIT | GH |
|---|---|---|
| Relative Strength Index (RSI) | 63.35 | 46.36 |
| Support Level | $254.61 | $82.33 |
| Resistance Level | N/A | $98.58 |
| Average True Range (ATR) | 7.18 | 4.65 |
| MACD | 0.88 | -0.06 |
| Stochastic Oscillator | 69.34 | 41.68 |
Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.